Gras R.,Hospital General Universitario Gregorio Maranoin |
Garciaa M.I.,Hospital General Universitario Gregorio Maranoin |
Gomez R.,Hospital General Universitario Gregorio Maranoin |
De La Mata F.J.,Hospital General Universitario Gregorio Maranoin |
And 2 more authors.
Molecular Pharmaceutics | Year: 2012
We studied changes in gene expression induced by the carbosilane dendrimer 2G-NN16 to evaluate their potential as a vehicle for gene therapy and as medication. Global gene expression profiles on CD8+ T lymphocytes reveal that ribosomal proteins are induced in the presence of 2G-NN16. IL17A and IL17F, the principal interleukins secreted by Tc17 cells, a subset of CD8+ T lymphocytes, were down-regulated when cultured in the presence of this dendrimer. Microarray results were confirmed by real time quantitative reverse transcriptase polymerase chain reaction (qRT-PCR). 2G-NN16 also showed a high potential for in vitro inhibition of Tc17 differentiation of CD8+ T lymphocytes in the presence of the Tc17 differentiation molecules IL6 and TGF-B1. These findings suggest that 2G-NN16 could facilitate drug delivery and may be used to treat inflammatory processes driven by Tc17 cells. © 2011 American Chemical Society. Source